Dennis W Raisch

Summary

Affiliation: University of New Mexico
Country: USA

Publications

  1. ncbi request reprint Opioid dependence treatment, including buprenorphine/naloxone
    Dennis W Raisch
    Veterans Affairs Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, 2401 Centre, SE, Albuquerque, NM 87106 4180, USA
    Ann Pharmacother 36:312-21. 2002
  2. ncbi request reprint Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children
    Dennis W Raisch
    Veterans Affairs Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, USA
    Value Health 6:158-66. 2003
  3. doi request reprint Health-related quality of life changes associated with buprenorphine treatment for opioid dependence
    Dennis W Raisch
    University of New Mexico, Albuquerque, NM, USA
    Qual Life Res 21:1177-83. 2012
  4. ncbi request reprint Impact of computerized prescriber order entry on the incidence of adverse drug events in pediatric inpatients
    Mark T Holdsworth
    College of Pharmacy, MSC09 5360, 1 University of New Mexico, Albuquerque, NM 87131 0001, USA
    Pediatrics 120:1058-66. 2007
  5. ncbi request reprint Impact of a clinical trials information handbook on patient knowledge, perceptions, and likelihood of participation
    Heather M Campbell
    Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, University of New Mexico College of Pharmacy, Albuquerque, NM, USA
    IRB 30:6-14. 2008
  6. doi request reprint Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's adverse event reporting system and review of case reports in the literature
    Dennis W Raisch
    Univeristy of New Mexico, College of Pharmacy, University of New Mexico, MSC 09 5360, Albuquerque, NM 87131, USA
    Expert Opin Drug Saf 13:15-23. 2014
  7. ncbi request reprint A comparison of veteran and nonveteran motivations and reasons for participating in clinical trials
    Heather M Campbell
    University of New Mexico College of Pharmacy, 2502 Marble, Albuquerque, NM 87131 0001, USA
    Mil Med 172:27-30. 2007
  8. ncbi request reprint Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence
    Dennis W Raisch
    Veterans Affairs Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, NM 87106, USA
    J Am Pharm Assoc (2003) 45:23-32. 2005
  9. doi request reprint Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes
    Heather M Campbell
    VA Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, United States University of New Mexico College of Pharmacy, Albuquerque, NM, United States Electronic address
    Diabetes Res Clin Pract 102:233-41. 2013
  10. doi request reprint Thrombocytopenia from combination treatment with oseltamivir and probenecid: case report, MedWatch data summary, and review of the literature
    Dennis W Raisch
    College of Pharmacy, University of New Mexico Health Sciences Center, 1 University of New Mexico, Albuquerque, NM 87131, USA
    Pharmacotherapy 29:988-92. 2009

Collaborators

Detail Information

Publications37

  1. ncbi request reprint Opioid dependence treatment, including buprenorphine/naloxone
    Dennis W Raisch
    Veterans Affairs Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, 2401 Centre, SE, Albuquerque, NM 87106 4180, USA
    Ann Pharmacother 36:312-21. 2002
    ..To review opioid dependence (OD) and its treatment. Pharmacologic treatments, including the use of buprenorphine/naloxone, are presented. Pharmaceutical care functions for outpatient OD treatment are discussed...
  2. ncbi request reprint Economic comparison of home-care-based versus hospital-based treatment of chemotherapy-induced febrile neutropenia in children
    Dennis W Raisch
    Veterans Affairs Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, USA
    Value Health 6:158-66. 2003
    ..The purpose of this study was to compare health-care resource utilization and outcomes among children treated for low-risk febrile neutropenia (FN) in a hospital-based setting with those treated in a home-care-based setting...
  3. doi request reprint Health-related quality of life changes associated with buprenorphine treatment for opioid dependence
    Dennis W Raisch
    University of New Mexico, Albuquerque, NM, USA
    Qual Life Res 21:1177-83. 2012
    ..Few studies have described improvement in health-related quality of life (HRQOL) associated with opioid dependence treatment with buprenorphine (ODT-B)...
  4. ncbi request reprint Impact of computerized prescriber order entry on the incidence of adverse drug events in pediatric inpatients
    Mark T Holdsworth
    College of Pharmacy, MSC09 5360, 1 University of New Mexico, Albuquerque, NM 87131 0001, USA
    Pediatrics 120:1058-66. 2007
    ..This study was conducted to determine the impact of a computerized physician order entry system with substantial decision support on the incidence and types of adverse drug events in hospitalized children...
  5. ncbi request reprint Impact of a clinical trials information handbook on patient knowledge, perceptions, and likelihood of participation
    Heather M Campbell
    Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, University of New Mexico College of Pharmacy, Albuquerque, NM, USA
    IRB 30:6-14. 2008
  6. doi request reprint Anaphylaxis associated with gadolinium-based contrast agents: data from the Food and Drug Administration's adverse event reporting system and review of case reports in the literature
    Dennis W Raisch
    Univeristy of New Mexico, College of Pharmacy, University of New Mexico, MSC 09 5360, Albuquerque, NM 87131, USA
    Expert Opin Drug Saf 13:15-23. 2014
    ..Although differences in numbers of reports of anaphylaxis reflect relative utilization rates of the various agents, disproportionality analyses (PRR, EBGM) disclose significant safety signals of anaphylaxis associated with most GBCAs. ..
  7. ncbi request reprint A comparison of veteran and nonveteran motivations and reasons for participating in clinical trials
    Heather M Campbell
    University of New Mexico College of Pharmacy, 2502 Marble, Albuquerque, NM 87131 0001, USA
    Mil Med 172:27-30. 2007
    ..Study delays often occur due to lack of recruitment. This study's primary objective was to compare veteran and nonveteran motivations and reasons...
  8. ncbi request reprint Pharmacists' and technicians' perceptions and attitudes toward dispensing buprenorphine/ naloxone to patients with opioid dependence
    Dennis W Raisch
    Veterans Affairs Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, NM 87106, USA
    J Am Pharm Assoc (2003) 45:23-32. 2005
    ..To assess the perceptions and attitudes of pharmacists and pharmacy technicians involved in an office-based opioid dependence treatment program using buprenorphine/naloxone...
  9. doi request reprint Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes
    Heather M Campbell
    VA Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, Albuquerque, NM, United States University of New Mexico College of Pharmacy, Albuquerque, NM, United States Electronic address
    Diabetes Res Clin Pract 102:233-41. 2013
    ....
  10. doi request reprint Thrombocytopenia from combination treatment with oseltamivir and probenecid: case report, MedWatch data summary, and review of the literature
    Dennis W Raisch
    College of Pharmacy, University of New Mexico Health Sciences Center, 1 University of New Mexico, Albuquerque, NM 87131, USA
    Pharmacotherapy 29:988-92. 2009
    ..001), but not probenecid. The underlying mechanism of thrombocytopenia with these drugs is unknown. Clinicians should be aware that the use of oseltamivir and probenecid has been reported to be associated with thrombocytopenia...
  11. doi request reprint Life-threatening dermatologic adverse events in oncology
    Alyx C Rosen
    aDepartment of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York bDepartment of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico cVeterans Affairs Cooperative Studies Program, Albuquerque, New Mexico dDepartment of Dermatology eRobert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois fDepartment of Internal Medicine, Division of Dermatology, Washington University School of Medicine, St Louis, Missouri, USA
    Anticancer Drugs 25:225-34. 2014
    ..Proactive pharmacovigilance to detect and define safety signals serves to aid oncology practitioners in the recognition of possible, yet uncommon, serious, and/or life-threatening skin reactions. ..
  12. doi request reprint Economic, clinical, and humanistic outcomes (ECHOs) of pharmaceutical care services for minority patients: a literature review
    Yan Cheng
    Department of Pharmacy Practice and Administrative Sciences, Pharmacoeconomics, Epidemiology, and Pharmaceutical Policy and Outcomes Research, College of Pharmacy, University of New Mexico, MSC 09 5360, 2502 Marble Avenue, NE, Albuquerque, NM 87131, USA
    Res Social Adm Pharm 9:311-29. 2013
    ..The U.S. population of racial/ethnic minorities continues to increase; however, health disparities and poor health outcomes among many of them continue to be a major public health problem confronting the U.S. health care system...
  13. doi request reprint Impact of United States Food and Drug Administration's boxed warnings on adverse drug reactions reporting rates and risk mitigation for multiple myeloma drugs
    Vishvas Garg
    University of New Mexico, College of Pharmacy, Albuquerque, NM 87131, USA
    Expert Opin Drug Saf 12:299-307. 2013
    ....
  14. doi request reprint A literature review of cost-effectiveness analyses of prostate-specific antigen test in prostate cancer screening
    Vishvas Garg
    Pharmacoeconomics, Epidemiology, Pharmaceutical Policy and Outcomes Research PEPPOR Program, Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM, USA
    Expert Rev Pharmacoecon Outcomes Res 13:327-42. 2013
    ..Further cost-effectiveness analyses reflecting latest clinical practice and current perspectives regarding adverse outcomes of potentially unnecessary treatment are required, especially from the US government perspective...
  15. doi request reprint Medication adherence assessment in a clinical trial with centralized follow-up and direct-to-patient drug shipments
    Stuart R Warren
    VA Cooperative Studies Program, Clinical Research Pharmacy Coordinating Center, 2401 Centre Ave SE, Albuquerque, NM 87106, USA
    Clin Trials 10:441-8. 2013
    ..Counting unused study medication is the predominant method by which adherence is assessed in outpatient clinical trials but it has limitations that include questionable validity and burdens on research personnel...
  16. pmc Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trial
    Dennis W Raisch
    University of New Mexico Health Sciences Center, 1 University of New Mexico, Albuquerque, NM 87131, USA
    Cardiovasc Diabetol 11:35. 2012
    ..We assessed relationships between HU and FT values and patient demographics and clinical variables...
  17. ncbi request reprint Acute and delayed nausea and emesis control in pediatric oncology patients
    Mark T Holdsworth
    Department of Pharmacy and Pediatrics, College of Pharmacy, University of New Mexico, Albuquerque, 87131, USA
    Cancer 106:931-40. 2006
    ..The current study was undertaken to determine the effectiveness of standard antiemetic interventions among children receiving emetogenic chemotherapy...
  18. ncbi request reprint GI risk factors and use of GI protective agents among patients receiving nonsteroidal antiinflammatory drugs
    Crystal L Harris
    Pharmaceutical Management and Research, Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy, Albuquerque, NM 87106 4180, USA
    Ann Pharmacother 40:1924-31. 2006
    ..Patients at risk may not be prescribed protective therapies that might mitigate their risk of NSAID-associated GI complications...
  19. ncbi request reprint Promoting good clinical practices in the conduct of clinical trials: experiences in the Department of Veterans Affairs Cooperative Studies Program
    Mike R Sather
    VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Research and Development, Albuquerque, New Mexico, USA
    Control Clin Trials 24:570-84. 2003
    ....
  20. ncbi request reprint The role of the pharmacy coordinating center in the DIG trial
    Carol L Fye
    Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, VA Medical Center, Albuquerque, New Mexico 87106 4180, USA
    Control Clin Trials 24:289S-297S. 2003
    ..As a direct result of involvement in the DIG trial, the PCC identified the need for an increased emphasis on computerization and automated support of clinical trials, especially LSTs...
  21. ncbi request reprint Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296
    Stuart S Winter
    Department of Pediatrics, Albuquerque, New Mexico 87131, USA
    Pediatr Blood Cancer 46:179-86. 2006
    ....
  22. ncbi request reprint Pharmacoeconomic analysis of angiotensin-converting enzyme inhibitors in type 2 diabetes: a Markov model
    Heather M Campbell
    Veterans Affairs Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, NM 87106, USA
    Ann Pharmacother 41:1101-10. 2007
    ..Prevention of cardiovascular disease (CVD) events by initiating an angiotensin-converting enzyme (ACE) inhibitor on diagnosis of type 2 diabetes may increase survival and decrease costs...
  23. ncbi request reprint Incidence and impact of adverse drug events in pediatric inpatients
    Mark T Holdsworth
    College of Pharmacy, University of New Mexico, 2502 Marble NE, Albuquerque, NM 87131 5691, USA
    Arch Pediatr Adolesc Med 157:60-5. 2003
    ..To determine the incidence and causes of adverse drug events (ADEs) and potential ADEs in hospitalized children, and to examine the consequences of these events...
  24. doi request reprint Use of number needed to treat in cost-effectiveness analyses
    Vishvas Garg
    Pharmacoeconomics, Epidemiology, Pharmaceutical Policy, and Outcomes Research program, Department of Pharmacy Practice and Administrative Sciences, College of Pharmacy, University of New Mexico, Albuquerque, NM, USA
    Ann Pharmacother 47:380-7. 2013
    ..To review the use of number needed to treat (NNT) and/or number needed to harm (NNH) values to determine their relevance in helping clinicians evaluate cost-effectiveness analyses (CEAs)...
  25. ncbi request reprint Pain and distress from bone marrow aspirations and lumbar punctures
    Mark T Holdsworth
    Pharmacy and Pediatrics, College of Pharmacy, University of New Mexico, Albuquerque, NM 87131 1066, USA
    Ann Pharmacother 37:17-22. 2003
    ..To compare the efficacy of 3 different pharmacologic regimens to relieve pain and distress in children with cancer undergoing bone marrow aspirations (BMAs) and lumbar punctures (LPs)...
  26. doi request reprint Relationship between diet, exercise habits, and health status among patients with diabetes
    Heather M Campbell
    VA Cooperative Studies Program Clinical Research Pharmacy Coordinating Center, Albuquerque, NM 87106, USA
    Res Social Adm Pharm 7:151-61. 2011
    ..Similarly, diets rich in fruits or vegetables (5-13 servings) have been found to lower the risk of stroke, cardiovascular conditions, cancer, and diabetes...
  27. ncbi request reprint Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): an overview from the research on adverse drug events and reports (RADAR) project
    June M McKoy
    Division of Geriatric Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, 303 E Chicago, Chicago, IL 60611, USA
    Leuk Res 31:599-604. 2007
    ....
  28. doi request reprint Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia
    Charles L Bennett
    VA Chicago Healthcare System, Department of Medicine, Northwestern University Feinberg School of Medicine, and Robert H Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois 60611, USA
    JAMA 299:914-24. 2008
    ..Although systematic overviews of trials have identified venous thromboembolism (VTE) risks, none have identified mortality risks with ESAs...
  29. ncbi request reprint Assessment of the impact of a patient clinical trials handbook among pharmacy students
    A Christie Graham
    University of Wyoming School of Pharmacy, Laramie, Wyoming, USA
    Clin Ther 27:238-45. 2005
    ..It has been suggested that patients' knowledge and attitudes are improved by being given general written information about clinical trials...
  30. ncbi request reprint Amiodarone versus sotalol for atrial fibrillation
    Bramah N Singh
    Department of Veterans Affairs Medical Center, West Los Angeles, Calif 90073, USA
    N Engl J Med 352:1861-72. 2005
    ..The optimal pharmacologic means to restore and maintain sinus rhythm in patients with atrial fibrillation remains controversial...
  31. ncbi request reprint Hypersensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project
    Jonathan R Nebeker
    Veterans Administration Salt Lake City, Salt Lake City, Utah, USA
    J Am Coll Cardiol 47:175-81. 2006
    ..We undertook the review of all available cases of hypersensitivity reactions after placement of a drug-eluting stent (DES) and classified potential causes...
  32. ncbi request reprint Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project
    Steven M Belknap
    Division of General Internal Medicine, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Cancer 106:2051-7. 2006
    ....
  33. ncbi request reprint Thalidomide- and lenalidomide-associated thromboembolism among patients with cancer
    Charles L Bennett
    JAMA 296:2558-60. 2006
  34. ncbi request reprint Systematic review of piperacillin-induced neutropenia
    Marc H Scheetz
    Department of Pharmacy, Northwestern Memorial Hospital, Chicago, IL 60611, USA
    Drug Saf 30:295-306. 2007
    ..Report of neutropenia associated with piperacillin usage prior to 15 days of therapy is a novel finding that requires further evaluation. Current reporting methods poorly characterise patient groups at risk...
  35. pmc Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project
    Charles L Bennett
    VA Center for Management of Complex Chronic Care at Jesse Brown VA Medical Center, Division of Hematology Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA
    J Am Coll Cardiol 50:1138-43. 2007
    ..We sought to describe clinical and laboratory findings for a large cohort of patients with thienopyridine-associated thrombotic thrombocytopenic purpura (TTP)...
  36. ncbi request reprint Dissemination of information on potentially fatal adverse drug reactions for cancer drugs from 2000 to 2002: first results from the research on adverse drug events and reports project
    Lisa A Ladewski
    Veterans Affairs Midwest Center for Health and Policy Research, Lakeside Division, Northwestern University Medical Center, Chicago, IL 60611, USA
    J Clin Oncol 21:3859-66. 2003
    ..To describe the clinical findings, occurrence rates, causality evidence, and dissemination media for serious cancer drug-associated adverse drug reactions (ADRs) reported in the postmarketing setting...
  37. ncbi request reprint Direct health care costs of 4 common skin ulcers in New Mexico Medicaid fee-for-service patients
    Ritesh N Kumar
    College of Pharmacy, University of Michigan, Ann Arbor, MI, USA
    Adv Skin Wound Care 17:143-9. 2004
    ..To determine health care costs associated with pressure ulcers, ulcers of the lower limbs, other chronic ulcers, and venous leg ulcers from the New Mexico Medicaid fee-for-service program perspective...